Information disclosed when screening for Down syndrome: A decision-making aid for pregnant women?;Information délivrée lors du dépistage de la trisomie 21: Une aide à la décision des femmes enceintes?

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 30, Issue 1 SUPPL., 2001, Pages 80-84

  Seror, V ^a   Ayme S ^a  

^a INSERM   (France)

Author keywords

Decision making; Down's syndrome; Information; Screening

Indexed keywords

DATA ANALYSIS; DECISION MAKING; DOWN SYNDROME; EXPECTATION; HEALTH PRACTITIONER; HUMAN; PATIENT SATISFACTION; PREGNANCY; PRENATAL DIAGNOSIS; REVIEW;

ATTITUDE TO HEALTH; DECISION SUPPORT TECHNIQUES; DOWN SYNDROME; FEMALE; FRANCE; HUMANS; MASS SCREENING; PATIENT EDUCATION; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRES; TRUTH DISCLOSURE;

EID: 0035135183     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Risk, autonomy, and responsibility. Informed consent for prenatal testing
2. Patients preferences for risk disclosure and role in decision making for invasive medical procedures
3. Rapport soumis au groupe de travail chargé d'élaborer des recommandations destinées aux médecins relatives l'information des patients
4. Shared decision-making in the medical encounter: What does it means? (or it takes at least two to tango)
5. Informed consent. The whole truth for patients?
6. Towards informed decisions about prenatal testing: A review
7. Nondirectiveness in genetic counseling: A survey of practitioners
8. Psychological nondirectiveness aspects of genetics counseling - Nondirectiveness revisited
9. Counselling following diagnosis of a fetal abnormality: The differing approaches of obstetricians, clinical geneticists, and genetic nurses
10. Dépistage prénatal de la trisomie 21 par marqueurs sériques maternels: De l'information à la prise de décision des femmes enceintes
11. Informed consent to serum screening for Down syndrome: Are women given adequate information?
12. Survey of attitudes of pregnant women towards Down syndrome screening
13. How women deal with the results of serum screening for Down syndrome in the second trimester of pregnancy
14. On what grounds do women participate in prenatal screening?
15. Evaluation patients's knowledge of maternal serum screening
16. Women's decision-making in prenatal screening
17. Experiences of mothers participating in maternal serum screening for Down's syndrome
18. Women's opinions on the offer and use of maternal serum screening
19. Audit of maternal serum screening: Strategies to augment counselling in response to women's views
20. Results and views of women in population-wide pregnancy screening for trisomy 21 in east Finland
21. Numbers or words? A randomized controlled trial of presenting screen negative results to pregnant women
22. The choices women make about prenatal diagnosis
23. Anxiety in women with low maternal serum alpha-fetoprotein screening results
24. Coping with serum screening for Down syndrome when the results is given as a numeric value
25. Impact of abnormal second-trimester maternal serum single, double, and triple screening on patient choices about prenatal diagnosis
26. The influence of serum screening on the amniocentesis rate in women of advanced maternal age
27. Genetic counselling: Information given, recall and satisfaction
28. Informed consent to undergo serum screening for Down's syndrome: The gap between policy and practice
29. Serum screening for Down's syndrome: How much do health professionals know?
30. Mastectomy or lumpectomy? Helping women make informed choices
31. Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia
32. A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer
33. La prise en compte des préférences des patients dans la décision thérapeutique en cancérologie: Développement d'un tableau de décision